Review




Structured Review

VectorBuilder GmbH control plasmid sh-scramble
Control Plasmid Sh Scramble, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid sh-scramble/product/VectorBuilder GmbH
Average 90 stars, based on 1 article reviews
control plasmid sh-scramble - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

90
VectorBuilder GmbH control plasmid sh-scramble
Control Plasmid Sh Scramble, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control plasmid sh-scramble/product/VectorBuilder GmbH
Average 90 stars, based on 1 article reviews
control plasmid sh-scramble - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Addgene inc non targeting scramble control shrna
Figure 8. Loss of EBP50 results in severe BB assembly defects in CACO-2BBE cells. (A) Confocal images of 12-day polarized CACO-2BBE cells stably expressing either a scramble <t>shRNA</t> construct or shRNAs targeting EBP50 (KD 37 and 64), stained for EBP50 (green) and F-
Non Targeting Scramble Control Shrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non targeting scramble control shrna/product/Addgene inc
Average 92 stars, based on 1 article reviews
non targeting scramble control shrna - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology scramble control shrna
Cellular effects of DYRK3 knockdown in ovarian cancer cells. (a, b) MTT assay showing decreased cell growth in both CAOV3 and OVCAR-3 cell lines following DYRK3 knockdown <t>by</t> <t>shRNAs.</t> Control cells treated with <t>scrambled-shRNA</t> or mock control exhibit higher growth rates. (c, d) Matrigel-Transwell assay demonstrating impaired invasion capacities in both CAOV3 and OVCAR-3 cell lines upon DYRK3 knockdown. ∗ indicates P < 0.05.
Scramble Control Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scramble control shrna/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
scramble control shrna - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology control sh scramble
Cellular effects of DYRK3 knockdown in ovarian cancer cells. (a, b) MTT assay showing decreased cell growth in both CAOV3 and OVCAR-3 cell lines following DYRK3 knockdown <t>by</t> <t>shRNAs.</t> Control cells treated with <t>scrambled-shRNA</t> or mock control exhibit higher growth rates. (c, d) Matrigel-Transwell assay demonstrating impaired invasion capacities in both CAOV3 and OVCAR-3 cell lines upon DYRK3 knockdown. ∗ indicates P < 0.05.
Control Sh Scramble, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/control sh scramble/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
control sh scramble - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

96
Addgene inc non targeting scrambled control shrna vector sh scr
Cellular effects of DYRK3 knockdown in ovarian cancer cells. (a, b) MTT assay showing decreased cell growth in both CAOV3 and OVCAR-3 cell lines following DYRK3 knockdown <t>by</t> <t>shRNAs.</t> Control cells treated with <t>scrambled-shRNA</t> or mock control exhibit higher growth rates. (c, d) Matrigel-Transwell assay demonstrating impaired invasion capacities in both CAOV3 and OVCAR-3 cell lines upon DYRK3 knockdown. ∗ indicates P < 0.05.
Non Targeting Scrambled Control Shrna Vector Sh Scr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non targeting scrambled control shrna vector sh scr/product/Addgene inc
Average 96 stars, based on 1 article reviews
non targeting scrambled control shrna vector sh scr - by Bioz Stars, 2026-02
96/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology non specific scrambled control sirna
Decreased ISG15 expression alters HTR8/SVneo cell morphology and reduces F- actin levels. (A–D) ISG15 mRNA (A) and protein levels (B) as well as cell morphology (C) and TRITC-conjugated Phalloidin (red) fluorescence stained F-actin levels (D) are represented in ISG15 <t>-siRNA</t> vs. control- siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test, n = 3, Scale bars = 30 µm (C) , Scale bars = 6 µm (D).
Non Specific Scrambled Control Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non specific scrambled control sirna/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
non specific scrambled control sirna - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

94
Addgene inc scramble control sh nc
Decreased ISG15 expression alters HTR8/SVneo cell morphology and reduces F- actin levels. (A–D) ISG15 mRNA (A) and protein levels (B) as well as cell morphology (C) and TRITC-conjugated Phalloidin (red) fluorescence stained F-actin levels (D) are represented in ISG15 <t>-siRNA</t> vs. control- siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test, n = 3, Scale bars = 30 µm (C) , Scale bars = 6 µm (D).
Scramble Control Sh Nc, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scramble control sh nc/product/Addgene inc
Average 94 stars, based on 1 article reviews
scramble control sh nc - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

90
Sangon Biotech plasmids containing scramble negative control (sh-nc)
Decreased ISG15 expression alters HTR8/SVneo cell morphology and reduces F- actin levels. (A–D) ISG15 mRNA (A) and protein levels (B) as well as cell morphology (C) and TRITC-conjugated Phalloidin (red) fluorescence stained F-actin levels (D) are represented in ISG15 <t>-siRNA</t> vs. control- siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test, n = 3, Scale bars = 30 µm (C) , Scale bars = 6 µm (D).
Plasmids Containing Scramble Negative Control (Sh Nc), supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmids containing scramble negative control (sh-nc)/product/Sangon Biotech
Average 90 stars, based on 1 article reviews
plasmids containing scramble negative control (sh-nc) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Figure 8. Loss of EBP50 results in severe BB assembly defects in CACO-2BBE cells. (A) Confocal images of 12-day polarized CACO-2BBE cells stably expressing either a scramble shRNA construct or shRNAs targeting EBP50 (KD 37 and 64), stained for EBP50 (green) and F-

Journal: Molecular Biology of the Cell

Article Title: The microvillar protocadherin CDHR5 associates with EBP50 to promote brush border assembly

doi: 10.1091/mbc.e23-02-0065

Figure Lengend Snippet: Figure 8. Loss of EBP50 results in severe BB assembly defects in CACO-2BBE cells. (A) Confocal images of 12-day polarized CACO-2BBE cells stably expressing either a scramble shRNA construct or shRNAs targeting EBP50 (KD 37 and 64), stained for EBP50 (green) and F-

Article Snippet: Knockdown studies utilized a non-targeting scramble control shRNA (Addgene; plasmid #46896), CDHR5 KD shRNA (TRC clone TRCN000054168; KD68), and EBP50 KD shRNA clones (TRCN0000043733; KD33), (TRCN0000043734; KD34), (TRCN0000043735; KD35), (TRCN0000043737; KD37), (TRCN0000440444; KD44) and (TRCN0000437164; KD64) sequences that were expressed from the pLKO.1 plasmid.

Techniques: Stable Transfection, Expressing, shRNA, Construct, Staining

Figure 9. Loss of CDHR5 results in BB assembly defects in CACO-2BBE cells. (A) Confocal images of 12-day polarized CACO-2BBE cells stably expressing either a scramble shRNA construct or an shRNA targeting CDHR5, stained for CDHR5, EBP50, Ezrin, and Phospho-ERM (P-ERM) (green) and F-actin (red). Boxed regions denote the area in zoomed image panels. Scale bars, 10 μm. Loss of CDHR5 expression disrupts proper apical assembly, but does not block apical targeting of Ezrin, activated Ezrin (detected by P-ERM antibody) and EBP50. (B) Scatterplot quantification of apical/total signal ratios of Ezrin, activated Ezrin (P-ERM) and EBP50 in scramble and CDHR5 KD CACO-2BBE cells. Each data point represents the ratio of the entire apical signal found in the x-z section compared to the total signal of the x-z section. Measurements of apical to total signal: EBP50 signal, scramble n=78, KD n=65; Ezrin signal, scramble n=74, KD n=56; P-ERM signal, scramble n=62, KD n=69. ns = not significant, *p < 0.01, two-tailed t test. (C) Cartoon proposing the new interactome of the IMAC, in which CDHR5 is cross-linked to the actin cytoskeleton via EBP50-Ezrin.

Journal: Molecular Biology of the Cell

Article Title: The microvillar protocadherin CDHR5 associates with EBP50 to promote brush border assembly

doi: 10.1091/mbc.e23-02-0065

Figure Lengend Snippet: Figure 9. Loss of CDHR5 results in BB assembly defects in CACO-2BBE cells. (A) Confocal images of 12-day polarized CACO-2BBE cells stably expressing either a scramble shRNA construct or an shRNA targeting CDHR5, stained for CDHR5, EBP50, Ezrin, and Phospho-ERM (P-ERM) (green) and F-actin (red). Boxed regions denote the area in zoomed image panels. Scale bars, 10 μm. Loss of CDHR5 expression disrupts proper apical assembly, but does not block apical targeting of Ezrin, activated Ezrin (detected by P-ERM antibody) and EBP50. (B) Scatterplot quantification of apical/total signal ratios of Ezrin, activated Ezrin (P-ERM) and EBP50 in scramble and CDHR5 KD CACO-2BBE cells. Each data point represents the ratio of the entire apical signal found in the x-z section compared to the total signal of the x-z section. Measurements of apical to total signal: EBP50 signal, scramble n=78, KD n=65; Ezrin signal, scramble n=74, KD n=56; P-ERM signal, scramble n=62, KD n=69. ns = not significant, *p < 0.01, two-tailed t test. (C) Cartoon proposing the new interactome of the IMAC, in which CDHR5 is cross-linked to the actin cytoskeleton via EBP50-Ezrin.

Article Snippet: Knockdown studies utilized a non-targeting scramble control shRNA (Addgene; plasmid #46896), CDHR5 KD shRNA (TRC clone TRCN000054168; KD68), and EBP50 KD shRNA clones (TRCN0000043733; KD33), (TRCN0000043734; KD34), (TRCN0000043735; KD35), (TRCN0000043737; KD37), (TRCN0000440444; KD44) and (TRCN0000437164; KD64) sequences that were expressed from the pLKO.1 plasmid.

Techniques: Stable Transfection, Expressing, shRNA, Construct, Staining, Blocking Assay, Two Tailed Test

Cellular effects of DYRK3 knockdown in ovarian cancer cells. (a, b) MTT assay showing decreased cell growth in both CAOV3 and OVCAR-3 cell lines following DYRK3 knockdown by shRNAs. Control cells treated with scrambled-shRNA or mock control exhibit higher growth rates. (c, d) Matrigel-Transwell assay demonstrating impaired invasion capacities in both CAOV3 and OVCAR-3 cell lines upon DYRK3 knockdown. ∗ indicates P < 0.05.

Journal: International Journal of Genomics

Article Title: Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 3 Expression and Its Correlation with Prognosis and Growth of Serous Ovarian Cancer: Correlation of DYRK3 with Ovarian Cancer Survival

doi: 10.1155/2024/6683202

Figure Lengend Snippet: Cellular effects of DYRK3 knockdown in ovarian cancer cells. (a, b) MTT assay showing decreased cell growth in both CAOV3 and OVCAR-3 cell lines following DYRK3 knockdown by shRNAs. Control cells treated with scrambled-shRNA or mock control exhibit higher growth rates. (c, d) Matrigel-Transwell assay demonstrating impaired invasion capacities in both CAOV3 and OVCAR-3 cell lines upon DYRK3 knockdown. ∗ indicates P < 0.05.

Article Snippet: For transfection, shRNAs targeting DYRK3 or scramble control shRNA were utilized, following the manufacturer's instructions (Cat. sc-39010-SH; Santa Cruz Biotechnology).

Techniques: Knockdown, MTT Assay, Control, shRNA, Transwell Assay

Decreased ISG15 expression alters HTR8/SVneo cell morphology and reduces F- actin levels. (A–D) ISG15 mRNA (A) and protein levels (B) as well as cell morphology (C) and TRITC-conjugated Phalloidin (red) fluorescence stained F-actin levels (D) are represented in ISG15 -siRNA vs. control- siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test, n = 3, Scale bars = 30 µm (C) , Scale bars = 6 µm (D).

Journal: Frontiers in Cell and Developmental Biology

Article Title: Preeclampsia is Associated With Reduced ISG15 Levels Impairing Extravillous Trophoblast Invasion

doi: 10.3389/fcell.2022.898088

Figure Lengend Snippet: Decreased ISG15 expression alters HTR8/SVneo cell morphology and reduces F- actin levels. (A–D) ISG15 mRNA (A) and protein levels (B) as well as cell morphology (C) and TRITC-conjugated Phalloidin (red) fluorescence stained F-actin levels (D) are represented in ISG15 -siRNA vs. control- siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test, n = 3, Scale bars = 30 µm (C) , Scale bars = 6 µm (D).

Article Snippet: The following day, cells were transiently transfected with either ISG15 -specific or non-specific scrambled control siRNA (Santa Cruz) in Opti-MEM media (Invitrogen) using Lipofectamine RNAiMAX Reagent (Invitrogen) according to the manufacturer’s instructions.

Techniques: Expressing, Fluorescence, Staining, Control, Transfection

ISG15 silencing reduces trophoblast migration, invasion and proliferation capacities. (A) In vitro wound healing (0–44 h), (B) migration ( n = 5, 48 h), and (C) invasion ( n = 5, 60 h) capacities, mRNA levels of (D) ITGB1 ( n = 3), (E) ITGB4 genes ( n = 3), as well as (F) proliferation ( n = 5, 48 h) and (G) apoptotic index ( n = 6, 48 h) are compared in control- vs. ISG15 -siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test. Scale bar = 500 µm.

Journal: Frontiers in Cell and Developmental Biology

Article Title: Preeclampsia is Associated With Reduced ISG15 Levels Impairing Extravillous Trophoblast Invasion

doi: 10.3389/fcell.2022.898088

Figure Lengend Snippet: ISG15 silencing reduces trophoblast migration, invasion and proliferation capacities. (A) In vitro wound healing (0–44 h), (B) migration ( n = 5, 48 h), and (C) invasion ( n = 5, 60 h) capacities, mRNA levels of (D) ITGB1 ( n = 3), (E) ITGB4 genes ( n = 3), as well as (F) proliferation ( n = 5, 48 h) and (G) apoptotic index ( n = 6, 48 h) are compared in control- vs. ISG15 -siRNA transfected HTR8/SVneo cells. Bars represent Mean ± SEM and compared by using t -test. Scale bar = 500 µm.

Article Snippet: The following day, cells were transiently transfected with either ISG15 -specific or non-specific scrambled control siRNA (Santa Cruz) in Opti-MEM media (Invitrogen) using Lipofectamine RNAiMAX Reagent (Invitrogen) according to the manufacturer’s instructions.

Techniques: Migration, In Vitro, Control, Transfection

ISG15 silencing amplifies IL-1β induced expression of pro-inflammatory cytokines. (A–D) Expression levels of IL1B , CXCL8 , IL6 , and CCL2 mRNA in control vs. ISG15 -siRNA transfected HTR8/SVneo cells, followed by 6 h treatment with vehicle (vh) or 10 ng/ml IL1β (IL-1β). (E,F) IL-6 and MCP-1, aka CCL2 , protein secretion levels in ISG15 -siRNA vs. control transfected HTR8/SVneo cells treated with 10 ng/ml IL1β (IL-1β). (A–D) : Bars represent median values and compared by using One way ANOVA, n = 4, * p = 0.007, Φ P = 0.005, ¥ p = 0.008, # p = 0.003. (E,F) : Bars represent Mean ± SEM and compared by using t -test ( n = 4).

Journal: Frontiers in Cell and Developmental Biology

Article Title: Preeclampsia is Associated With Reduced ISG15 Levels Impairing Extravillous Trophoblast Invasion

doi: 10.3389/fcell.2022.898088

Figure Lengend Snippet: ISG15 silencing amplifies IL-1β induced expression of pro-inflammatory cytokines. (A–D) Expression levels of IL1B , CXCL8 , IL6 , and CCL2 mRNA in control vs. ISG15 -siRNA transfected HTR8/SVneo cells, followed by 6 h treatment with vehicle (vh) or 10 ng/ml IL1β (IL-1β). (E,F) IL-6 and MCP-1, aka CCL2 , protein secretion levels in ISG15 -siRNA vs. control transfected HTR8/SVneo cells treated with 10 ng/ml IL1β (IL-1β). (A–D) : Bars represent median values and compared by using One way ANOVA, n = 4, * p = 0.007, Φ P = 0.005, ¥ p = 0.008, # p = 0.003. (E,F) : Bars represent Mean ± SEM and compared by using t -test ( n = 4).

Article Snippet: The following day, cells were transiently transfected with either ISG15 -specific or non-specific scrambled control siRNA (Santa Cruz) in Opti-MEM media (Invitrogen) using Lipofectamine RNAiMAX Reagent (Invitrogen) according to the manufacturer’s instructions.

Techniques: Expressing, Control, Transfection